Tranylcypromine in recurrent brief depression: two case reports.
Two cases are described in which patients with recurrent brief depression experienced a noticeable therapeutic response with the first generation monoamine oxidase inhibitor tranylcypromine. These reports are of interest in light of recent data suggesting that this subtype of depression does not respond to conventional antidepressants such as selective serotonin reuptake inhibitors.